Full-Time
BIM Coordinator
Ghobash Group
1,001-5,000 employees
Diversified group funding growth and partnerships
No salary listed
Dubai - United Arab Emirates
In Person
 Architecture & Civil Engineering (2) |
|---|
| , |
Get referred to Ghobash Group
See people who can refer or advise you
- Bachelor's in Architecture or Engineering.
- 10-15 years of BIM coordination experience in Middle East projects.
- Proficiency in Revit, Navisworks, AutoCAD, and BIM 360.
- Strong knowledge of LOD 200-500, MEP, ELV systems, and industry standards (DEWA, ASHRAE, NFPA).
- Expertise in clash detection, coordination, and resolution.
- Strong communication, problem-solving, and project management skills.
- Oversee QA/QC and BIM model submissions across multiple disciplines (Architecture, Structural, MEP, Infrastructure, etc.).
- Ensure compliance with BIM execution plans and project standards.
- Perform clash detection and resolution using Navisworks, Revit, and BIM 360.
- Provide guidance on workflows and software tools.
- Experience with Dynamo, scripting, and automation.
- Knowledge of Civil 3D for infrastructure.
- Familiarity with COBie, complex modeling, and detailing.
- BIM/Revit certification (e.g., Autodesk Certified Professional).
- On-Role, Long-Term Opportunity.
- Immediate Joiners Preferred.
- 5+ years of experience in respective BIM disciplines.
- Compliance with policies and procedures based on the ISO standards adopted by CNS.
- Excellent problem-solving and teamwork skills.
Ghobash Group focuses on growth, sustainability and value creation by nurturing and developing opportunities for both the public and private sectors. It partners with innovative products and services and leverages a diverse team of 3,000+ professionals, strong financial backing, and extensive regional experience to execute these opportunities. The company works by identifying, developing, and deploying initiatives intuitively and systematically through collaborations and operational capabilities, aiming to deliver solutions that meet growing needs and aspirations. What sets Ghobash Group apart is its combination of strategic growth focus, commitment to sustainability, broad regional reach, substantial financial strength, and strong execution ability, enabling it to move opportunities from idea to reality more reliably than competitors. Its goal is to push the boundaries for innovation and customer satisfaction while expanding value for partners and stakeholders.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Dubai, United Arab Emirates
Founded
1981
Get referred to Ghobash Group
See people who can refer or advise you
Simplify's Take
What believers are saying
- Cross-selling sector-specific solutions across technology, energy & utilities, and healthcare.[4][6]
- Multi-country GCC footprint supports regional rollout and integration projects.[4][7]
- Portfolio growth across operating companies and investments supports recurring partnership expansion.[5][8]
What critics are saying
- Conglomerate complexity dilutes management attention and slows capital allocation decisions.[6][10]
- Healthcare and technology subsidiaries face entrenched regional and multinational competition.[1][2]
- Governance remains concentrated in a privately held structure with key-person risk.[10][15]
What makes Ghobash Group unique
- Privately held UAE conglomerate with eight sectors and technology, energy, healthcare focus.[4][6]
- Operates subsidiaries and JVs, including GCG Enterprise Solutions and Emitac Enterprise Solutions.[2][8]
- Backs digitalization in KSA with cloud, cybersecurity, and document-management offerings.[3]
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Remote Work Options
Professional Development Budget
Conference Attendance Budget
Training Programs
Mentorship Program
Wellness Program
Mental Health Support
Gym Membership
Phone/Internet Stipend
Home Office Stipend
Company Equity
Stock Options
401(k) Retirement Plan
401(k) Company Match
Paid Vacation
Paid Holidays
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Childcare Support
Elder Care Support
Relocation Assistance
Sabbatical Leave
Performance Bonus
Profit Sharing
Employee Stock Purchase Plan
Commuter Benefits
Meal Benefits
Paid Sick Leave
Paid Holidays
PTO/vacation
Company News
Arabian Ethicals leads global discussion on cell and Gene Therapy at WHX Dubai 2026. Arabian Ethicals, a Ghobash Group enterprise, lead an insightful global discussion on cell and gene therapy at World Health Expo (WHX) Dubai 2026, the largest international gathering of healthcare professionals. Serving as a global platform for knowledge exchange and the advancement of healthcare practice, WHX Dubai took place at Expo City Dubai from 9 to 12 February. The panel was moderated by Ebru Yavuz, General Manager of Arabian Ethicals in the UAE, who guided the discussion on how advances in stem cell, cellular, and gene therapies are being implemented within real-world healthcare settings. Titled "Cell & Gene Therapy Waves: From Scientific Breakthroughs to Real-World Clinical Delivery," the session examined readiness, infrastructure, and long-term considerations influencing the adoption of these therapies. Throughout the discussion, Yavuz facilitated conversations around the operational and clinical realities faced by healthcare providers. Topics included the need for specialised facilities, multidisciplinary expertise, and clearly defined care pathways, alongside the importance of responsible scaling as advanced therapies move closer to routine clinical use. The session featured Prof. Marcos De Lima, Director of Stem Cell Transplant and Cellular Therapy at Ohio State University Wexner Medical Center, and Rabi Hanna, Chairman of Pediatric Hematology & Oncology and BMT, and Founding Director of the Pediatric Blood & Marrow Transplant Program at Cleveland Clinic Children's Hospital, USA. Both speakers shared insights drawn from established transplant and cellular therapy programmes, highlighting recent developments as well as ongoing challenges associated with translating complex therapies into everyday clinical practice. A key focus of the panel was pediatric care, where cell and gene therapies introduce additional clinical, logistical, and ethical considerations. The discussion addressed the importance of long-term follow-up, patient selection, and institutional readiness, as well as the role of academic medical centres in setting standards and supporting sustainable growth in the field. Commenting on the panel, Ebru Yavuz noted: "Innovation in cell and gene therapy is moving quickly, but the real challenge lies in how these advances are adopted within healthcare systems. Forums like WHX Dubai allow practitioners and industry leaders to share practical experience and discuss what is needed to deliver these therapies safely and effectively in clinical settings." The discussion aligns with the UAE's broader healthcare ambitions, which prioritise quality, innovation, and integrated care as part of the country's long-term national vision through 2031. Platforms such as WHX Dubai support these priorities by facilitating knowledge exchange and collaboration across specialised and emerging areas of healthcare. Arabian Ethicals' participation at WHX Dubai 2026 reflects its continued engagement in scientific dialogue and support for knowledge exchange across specialised therapeutic areas, contributing to the ongoing development of healthcare practice in the region. Visited 7 times, 7 visit(s) today
Elevating the benchmarks for Early Childhood Education in the UAE, Ghobash Group has announced a strategic exclusive partnership with HEI schools (Helsinki International Schools), the award-winning research-based Early Childhood Education model from Finland designed for ages 0-6 years.